Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aevi Genomic Medicine Inc

0.1659
+0.0000
Volume:- -
Turnover:- -
Market Cap:12.89M
PE:-0.56
High:0.1659
Open:0.1659
Low:0.1659
Close:0.1659
Loading ...
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 12, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 12, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 12, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 12, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 12, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 12, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 07, 2020

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Feb 03, 2020

Delisting

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Feb 03, 2020

Major Issues Report

Current report, items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.07, and 9.01
Jan 06, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 23, 2019

Business Combinations

Prospectuses and communications, business combinations
Dec 23, 2019

Business Combinations

Prospectuses and communications, business combinations
Dec 23, 2019

Major Issues Report

Current report, items 3.02, 7.01, 8.01, and 9.01
Dec 11, 2019

Business Combinations

Prospectuses and communications, business combinations
Dec 11, 2019

Major Issues Report

[Amend] Current report, items 1.01 and 9.01
Dec 11, 2019

Business Combinations

Prospectuses and communications, business combinations
Dec 10, 2019

Business Combinations

Prospectuses and communications, business combinations